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2001). In addition, studies from a number of laboratoriesSummary
have pointed toward the role of red blood cells (RBCs)
and derived NO bioactivity, in the integrated vascularThe current perspective of NO biology is formulated
response that regulates arteriolar resistance (Cirillo etpredominantly from studies of NO synthesis. The role
al., 1992; Gonzalez-Alonso et al., 2002; McMahon et al.,of S-nitrosothiol (SNO) formation and turnover in gov-
2002). NO itself is not detected in blood or tissues. So theerning NO-related bioactivity remains uncertain. We
idea has been raised that SNOs contribute to vasculargenerated mice with a targeted gene deletion of
homeostasis (Foster et al., 2003; Gow et al., 2002).S-nitrosoglutathione reductase (GSNOR), and show
Higher output production of NO/RNS, typically by thethat they exhibit substantial increases in whole-cell
inducible NOS (iNOS), can disrupt cellular functionS-nitrosylation, tissue damage, and mortality following
(Moncada et al., 1991; Nathan and Xie, 1994). This patho-endotoxic or bacterial challenge. Further, GSNOR/
physiological situation, termed nitrosative stress (Haus-mice have increased basal levels of SNOs in red blood
laden et al., 1996), has been likened to oxidative stresscells and are hypotensive under anesthesia. Thus,
caused by reactive oxygen species (ROS) (HausladenSNOs regulate innate immune and vascular function,
et al., 1996; Hausladen and Stamler, 1999). But whereasand are cleared actively to ameliorate nitrosative
studies of superoxide dismutase, catalase, and peroxi-stress. Nitrosylation of cysteine thiols is a critical
dases have provided incontrovertible genetic evidencemechanism of NO function in both health and disease.
for an enzymatic defense against ROS, the role and
mechanism of RNS detoxification in multicellular organ-Introduction
isms is unknown. Nonetheless, accumulating evidence
points to the existence of a nitrosative stress-responseThree classes of nitric oxide (NO) synthase (NOS) play
that subserves NO/SNO homeostasis. In particular,important roles in a wide range of cellular functions and
iNOS expression coincides with an increase in S-nitro-in host defense (Moncada et al., 1991; Nathan and Xie,
sylated proteins, which rapidly reaches a new steady-1994). The expression, regulation, and activities of these
state level (Eu et al., 2000; Marshall and Stamler, 2002).enzymes have been studied extensively through both
These data suggest that SNOs are being actively de-
genetic and pharmacological approaches. The events
graded.
downstream of NO synthesis are, however, much less
Expression of iNOS is strongly induced in septic
well understood. It has been proposed that S-nitrosyla- shock, a complex syndrome that claims over 100,000
tion of cysteine thiols constitutes a significant route human lives per year in the United States alone (Feihl
through which NO bioactivity is transduced, serving to et al., 2001). The role of iNOS in septic and endotoxic
stabilize and diversify NO-related signals, and as a ubiq- shock has been probed extensively in mice. Notably,
uitous regulatory modification of a broad spectrum of the original analyses of two independently generated
proteins (Boehning and Snyder, 2003; Foster et al., 2003; iNOS-deficient (iNOS/) mouse lines did not reveal clear
Stamler et al., 2001). Evidence in favor of this proposition differences in mortality when compared with wild-type
includes: (1) the presence of S-nitrosothiol (SNO) deriva- controls (Laubach et al., 1995; MacMicking et al., 1995).
tives of peptides and proteins in most tissues and extra- However, more thorough studies of these mice showed
cellular fluids under basal conditions (Gaston et al., that iNOS deficiency actually increased mortality follow-
1993; Gow et al., 2002; Jaffrey et al., 2001; Jia et al., ing lipopolysaccharide (LPS) challenge (Laubach et al.,
1996; Kluge et al., 1997; Mannick et al., 1999; Rodriguez 1998; Nicholson et al., 1999), indicating a protective role
et al., 2003; Stamler et al., 1992); (2) examples of physio- of iNOS in this model. The protection by iNOS was mainly
logical responses that are uniquely recapitulated by spe- evident in females (Laubach et al., 1998). Consistent with
cific SNOs (De Groote et al., 1996; Lipton et al., 2001; these data, the iNOS inhibitors 1400W and N-(1-imino-
ethyl)-L-lysine, either have little effect or worsen injury
in animal models of endotoxic shock (Feihl et al., 2001;*Correspondence: staml001@mc.duke.edu
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An S-nitrosoglutathione (GSNO) reductase (GSNOR), tal of 7–10 times. The GSNO reductase activity is absent
in both tail and tissues of GSNOR/ mice (Figureconserved across phylogeny, has recently been identi-
fied (Jensen et al., 1998; Liu et al., 2001). This enzyme 1D and 1E), whereas the activity in heterozygous
(GSNOR/) mice is roughly half that in wild-type lit-is formally an alcohol dehydrogenase (ADH III; also
known as glutathione-dependent formaldehyde dehy- termates.
drogenase) (Uotila and Koivusalo, 1989), but shows
much greater activity toward GSNO than any other sub- Phenotype
strate (Jensen et al., 1998; Liu et al., 2001). GSNOR We bred heterozygous males and females under patho-
appears to be the major GSNO-metabolizing activity in gen-free conditions and obtained 31 (25%) wild-type,
eukaryotes (Liu et al., 2001). Thus, GSNO can accrue in 61 (50%) heterozygous, and 30 knockout (25%) mice
extracellular fluids where GSNOR activity is low or ab- at weaning. Thus, the inheritance of the wild-type and
sent (e.g., airway lining fluid) (Gaston et al., 1993), but disrupted GSNOR gene followed the expected Mende-
cannot be detected readily inside cells (Eu et al., 2000; lian ratio, and GSNOR-deficient mice did not show a
Liu et al., 2001). Yeast deficient in GSNOR accumulate survival disadvantage under these conditions.
S-nitrosylated proteins (which are not substrates of the GSNOR/ mice reproduced litters with a size and
enzyme), indicating that GSNO exists in equilibrium with frequency similar to C57BL/6 mice (Figure 1F). They
SNO-proteins (Liu et al., 2001). Such precise control developed normally and weighed the same as C57BL/6
over ambient levels of GSNO and SNO-proteins raises mice (Figure 1F). Histological examination of 4 wild-type
the idea that GSNO/GSNOR may play roles in both phys- (2 males, 2 females) and 4 GSNOR/ mice (2 males, 2
iological signaling and protection against nitrosative females) showed no gross morphological or histological
stress. Indeed, GSNO has been implicated in responses difference between the two mouse strains in any of the
ranging from the drive to breathe (Lipton et al., 2001) to tissues studied: brain, heart, lung, liver, kidney, spleen,
regulation of the cystic fibrosis transmembrane regula- thymus, mesenteric lymph node, salivary gland, gastro-
tor (Zaman et al., 2001) and host defense (de Jesus- intestinal tract, pancreas, testis, ovary, uterus, and uri-
Berrios et al., 2003), and we have found that GSNOR nary bladder. Blood cell counts and serum chemistries
protects yeast cells against nitrosative stress both in were normal in GSNOR/ mice (see more below).
vitro (Liu et al., 2001) and in vivo (de Jesus-Berrios et
al., 2003). Blood Pressure and Basal SNO
In this paper, we describe the generation of GSNOR- It is known that hemodynamic responses to SNOs are
deficient (GSNOR/) mice through homologous recom- affected by anesthesia, although the mechanism is un-
bination, and the response of the mice to a nitrosative explained (Travis et al., 1997). Blood pressure was much
challenge (induced principally by LPS). Our choice of lower in GSNOR/ mice than in the wild-types (P 
the bacterial endotoxin model of shock is militated by 0.001) when anesthetized with urethane (Figure 2A). On
the multitude of factors that, in alternative models of the other hand, blood pressure in conscious GSNOR/
septic shock, inevitably obscure the elucidation of the mice did not differ from the controls (Figure 2B). Most
specific roles of SNOs in governance of NO bioactivity— of the NO in blood is found in red blood cells (RBCs) as
our principal objective. That being said, we have also iron nitrosyl hemoglobin and SNO-hemoglobin (Jia et
studied a bacterial model of sepsis to strengthen the al., 1996; Kirima et al., 2003; McMahon et al., 2002;
case for physiological relevance. We report that GSNOR Milsom et al., 2002). Levels of SNO-Hb (RBC-SNO) were
is indispensable for SNO metabolism, for vascular ho- higher in unanesthetized GSNOR/ mice than in wild-
meostasis, and for survival in endotoxic shock. type mice (P 0.05), whereas levels of iron nitrosyl hemo-
globin did not differ between wild-type and GSNOR/
(Figure 2C). Thus, GSNOR deficiency leads to increasesResults
in basal SNO, and predisposes mice to dysregulation
of blood pressure. Following endotoxin, diminished andGeneration of GSNOR/ Mice
irregular tail blood flow in unanesthetized mice and lowThe GSNOR gene consists of nine exons (Foglio and
blood pressure in anesthetized mice, precluded accu-Duester, 1996); exons 5 and 6 encode most of the coen-
rate measurement of blood pressure by either approach.zyme binding domain of GSNOR (Yang et al., 1997). A
targeting vector constructed with GSNOR genomic DNA
was employed to replace exons 5 and 6 with a neomycin Mortality from Endotoxic Shock
LPS-induced shock was used as a model of nitrosativeresistance gene (neo) through homologous recombina-
tion in mouse (129sv) embryonic stem (ES) cells (Figure stress. In initial dose-response studies, we established
the dose of LPS that produces 50% mortality in1). Homologous recombination on both sides flanking
the targeted region was confirmed in four ES clones by GSNOR/ mice (Figure 3). In a larger analysis, this dose
of LPS resulted in the death of 48% of GSNOR/ mice,two Southern blot analyses with probes specific to ex-
ons 2–3 and exons 8–9 respectively and by a polymerase but only 15% of wild-type mice (Figure 3A). The differ-
ence in mortality between the two strains is highly signifi-chain reaction (PCR) specific to the disrupted allele (Fig-
ure 1B, and data not shown). Two mouse lines with the cant (P 0.001). Further, both lines of GSNOR-knockout
mice, GSNOR/1 and GSNOR/2, responded similarlytargeted disruption were independently generated from
two of the ES clones (Figure 1C). Southern hybridization to LPS (Figure 3B), and both succumbed more readily
than wild-type mice. Thus, it is very unlikely that thewith a probe specific to exons 8–9 showed that
GSNOR/ mice contain only a single mutant (1.8 kb) hypersensitivity of GSNOR/ mice to LPS resulted from
a random mutation created while generating the mice.fragment that resulted from recombination. These mice
were backcrossed consecutively to C57BL/6 mice a to- The protection conferred by iNOS in endotoxic shock
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Figure 1. Targeted Disruption of the GSNOR Gene
(A) Strategy for targeted disruption of the GSNOR gene. The structures of the targeting vector, wild-type, and disrupted GSNOR alleles are
shown. The restriction sites used for construction of the targeting vector and Southern analysis are: B, BamHI; H, HindIII; N, NotI; S, SacI; X,
XbaI. Cassettes PGKneo and PGKtk are the selectable genes neo and tk respectively, under control of the mouse phosphoglycerokinase
gene promoter. Double-headed arrows represent expected fragments of wild-type and disrupted GSNOR alleles in Southern analyses with
SacI or XbaI restriction. Neo3se and GSNOR3as are the PCR primers used to detect the disrupted allele.
(B) Southern analysis of genomic DNA from GSNOR-targeted ES clones. The DNA was digested with SacI and probed with ex2-3, a cDNA
probe specific for exons 2-3 of GSNOR. WT, wild-type; KO, disrupted allele.
(C) Southern analysis of genomic DNA from wild-type (/), heterozygous (/) and GSNOR null (/) mice. DNA was digested with XbaI
and hybridized with ex8-9, a probe specific for exons 8-9.
(D) GSNOR activity in mouse tails. Data are the means ( SD) of 2–4 samples.
(E) GSNOR activities in various tissues. Protein extracts (500 g/ml) were incubated with 200 M NADH and 0 or 150 M GSNO. Values are
from 3 wild-type (filled) or 2 GSNOR/ (open) mice.
(F) Body weights of 80-day-old mice (n  18–29) and litter sizes at weaning (n  16–32). Mice from wild-type (open), GSNOR/ line one
(streaked) and line two (filled) were raised on a standard mouse diet in the same animal facility.
is mainly seen in female mice (Laubach et al., 1998). We this gender effect was abrogated by GSNOR deletion.
Mortality in female GSNOR/mice (42%) was not signif-therefore analyzed the consequence of GSNOR defi-
ciency separately in males (Figure 3C) and females (Fig- icantly lower than that of male knockouts (55%; P 
0.29). Taken together, these results show that GSNORure 3D). The LPS dose employed resulted in the death
of 37% and 47% of the female GSNOR/1 and clearly protects female mice from endotoxic shock, and
suggest that the basis of gender-related resistance toGSNOR/2 respectively, whereas it killed only 4% of
wild-type controls (Figure 3D). The mortality of male LPS involves GSNOR. Accordingly, female mice were
used in most of studies below.GSNOR/ mice (treated with LPS) was also higher than
that of wild-type controls (Figure 3C), but the difference
did not reach statistical significance (P  0.12). The SNO Metabolism
Metabolism of S-nitrosothiols was examined in mousemortality of female wild-type mice (4%) was significantly
lower than their male counterparts (29%; P 0.022), but liver, which has the highest GSNOR activity in the body
Cell
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Figure 2. Blood Pressure and S-Nitrosothiols
in Wild-Type Versus GSNOR/ Mice
(A) Mean arterial pressure in anesthetized
C57BL/6 (WT) and GSNOR/ (KO) mice. Data
are the means  SE of two males and two
females in each strain (i.e., n  4 per strain).
(B) Systolic blood pressure in conscious
mice. Data are the means SE of 8 C57BL/6
(4 males) and 12 GSNOR/ (4 males) mice.
(C) Nitrosylation in RBCs from unanesthe-
tized wild-type (open) and GSNOR/ (filled)
mice. SNO-Hb levels in GSNOR/ mice are
significantly higher than in wild-type mice
(P  0.05, n  12), whereas iron-nitrosylHb
levels are not different.
(Figure 1E) (Uotila and Koivusalo, 1997), and also ex- respectively, 3.3-fold and 29-fold greater than in wild-
type controls. Over 90% of the SNO could be ascribedpresses substantial iNOS activity during septic shock
(Knowles et al., 1990). Hepatic iNOS is protective in this to molecules of high mass (5,000 dalton; Figure 4A).
Thus, in endotoxic shock, the metabolism of endoge-situation (Ou et al., 1997). The SNO levels of GSNOR/
mice were similar to those of wild-type mice at baseline nously generated nitrosothiols is severely impaired in
the GSNOR-deficient mouse.(Figure 4A). In the wild-type mice, SNOs increased mod-
estly at 24 hr (h) after i.p. injection of LPS and returned The levels of nitrate plus nitrite (NOx) in the circulation
reflect overall NOS activity in mammals. Basal nitrateto basal levels by 48 hr (Figure 4A). In contrast, SNOs
accumulated to much higher levels in GSNOR/ mice and nitrite levels in GSNOR/ mice do not differ from
wild-type mice (Figures 4B, 4C, and Experimental Proce-at 24 hr and increased further at 48 hr (Figure 4A). At
24 hr and 48 hr, SNO levels in the GSNOR/ mice were, dures). After treatment with LPS, nitrate concentrations
Figure 3. Increased Mortality from Endotoxic
and Septic Shock in GSNOR/ Mice
(A) Survival of GSNOR/ mice (filled circles,
n  69) was significantly lower than that of
wild-type mice (open circles, n  39) follow-
ing intraperitoneal injection of LPS (P 
0.001).
(B) Survival of mice from GSNOR/ line one
(GSNOR/1, upright triangle; n 37) and line
two (GSNOR/2, inverted triangle; n  32)
was similar. Both values were significantly
lower than the wild-type mice (open circles,
n  39) after LPS (P  0.002 for GSNOR/1;
P  0.004 for GSNOR/2).
(C) Survival of male GSNOR/ mice (filled
circles, n  31) was not significantly lower
than wild-type controls (open circles, n  16)
after LPS (P  0.12).
(D) Survival of both female GSNOR/1 (up-
right triangle; P  0.01, n  19) and female
GSNOR/2 (inverted triangle; P 0.002, n
19) mice was significantly lower than wild-
type controls (open circles, n 23) after LPS.
(E) Survival of GSNOR/ female mice (filled,
n  9) was significantly lower than that of
wild-type controls (open, n  8) following ce-
cal ligation and puncture (CLP; P  0.03).
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Figure 4. Abnormal SNO Metabolism in
GSNOR/ Mice
(A) Liver S-nitrosothiols in wild-type and
GSNOR/mice after intraperitoneal injection
of PBS (48 hr) or LPS. Levels of SNO in
GSNOR/ mice are significantly higher than
in wild-type controls at both 24 hr (P 0.005)
and 48 hr (P  0.006) after LPS challenge.
(B) Serum nitrate in wild-type (open) and
GSNOR/ (filled) mice. Nitrate levels in
GSNOR/ mice are significantly higher (P 
0.016) than in wild-type controls at 48 hr
after LPS.
(C) Serum nitrite in wild-type (open) and
GSNOR/ (filled) mice.
(D) Elevated ratios of liver SNO to serum ni-
trate are significantly higher (P  0.010) at 48
hr than 24 hr after LPS in GSNOR/ mice.
(Analysis was carried out on mice with signifi-
cantly elevated nitrate levels (100 M)).
(E) The level of liver SNO is significantly higher
(P  0.007) in GSNOR/ (filled) mice than in
wild-type (open) controls at 72 hr after CLP.
in wild-type mice rose at 24 hr to the same level as in elevations in liver SNO in GSNOR/ mice (Figure 5H).
Histological examination of the liver at 24 hr (after LPS)GSNOR/mice and returned to baseline at 48 hr (Figure
4B). However, while the nitrate level in GSNOR/ mice showed minimal to mild hepatocellular swelling and cy-
toplasmic vacuolation in the wild-type mice. By 48 hr,had decreased at 48 hr (50%, P  0.03), it was still
substantially elevated above baseline (Figure 4B). The the damage had partly resolved (more so in females
than males) and no ongoing injury was detected (Figurelevels of serum nitrite (nitrate) were not significantly
different at any time-point in wild-type and mutant ani- 6A). Hepatocellular injury was more severe in the
GSNOR/ mice at 24 hr and no recovery was evidentmals (Figure 4C; data not shown). These data suggest
that wild-type and GSNOR/ mice express equal iNOS at 48 hr (Figures 6A and 6B). At 24 hr and 48 hr, multifocal
necrotic and apoptotic hepatocytes were detected inactivity at 24 hr after LPS, but whereas iNOS activity
returns to baseline by 48 hr in wild-type mice, the decline GSNOR/ mice (hyaline eosinophilic cytoplasm and
pyknotic and karyorrhectic nuclei; Figure 6B, and datain activity is slower in GSNOR/ mice. This conclusion
was confirmed at the level of iNOS expression by West- not shown). In addition, GSNOR/ livers contained dis-
rupted hepatic cords, compressed sinusoids, small ag-ern blot analyses of liver lysates (data not shown).
Although steady-state S-nitrosylation is elevated in gregates of degenerating granulocytes, and subintimal
accumulations of granulocytes and lymphocytes in ven-animals with elevated nitrate concentrations, it is clear
that SNO levels in tissues are independent of NOx (Figure ules. Thus, both the serum markers and histopathology
indicate that LPS-induced liver damage in GSNOR/4). For example, GSNOR/ mice accumulated much
higher amounts of SNO than wild-types despite equal mice was much worse than in wild-type mice and, in
sharp contrast to the near complete recovery by wild-levels of nitrate at 24 hr after LPS (Figures 4A and 4B).
Furthermore, the ratio of liver SNO to serum nitrate in type livers, GSNOR/ livers showed no sign of recovery.
The marker of muscle injury, creatine phosphokinaseGSNOR/ mice was considerably higher at 48 hr than
at 24 hr after LPS (Figure 4D). Thus, the level of (CPK), and the markers of kidney dysfunction, urea nitro-
gen (BUN) and creatinine, all increased substantially andS-nitrosylation in vivo is regulated independently by
GSNOR and NOS. Alternatively stated, SNO levels are to similar levels in wild-type and GSNOR/ mice at 24
hr after LPS (Figures 5C–5E). But whereas these activi-regulated by both synthesis and turnover and do not
correlate directly with amounts of nitrate or nitrite. ties had decreased at 48 hr almost to baseline in the
wild-type controls, they did not decline in the GSNOR/
mice (Figures 5C–5E). Thus, organ dysfunction did notTissue Injury and Recovery Following
resolve in the GSNOR/ mice. The kidneys and heartsEndotoxin Challenge
of the wild-type and GSNOR/ mice were grossly nor-Tissue injury during endotoxic shock was assessed by
mal on histological examination.measurement of serum levels of marker enzymes (Figure
Although pancreatic islet cells are highly susceptible5) and histopathology (Figure 6). In wild-type mice, levels
to NO toxicity in vitro (Liu et al., 2000a), LPS challengeof alanine aminotransferase (ALT) and aspartate amino-
had little effect on the pancreas in wild-type andtransferase (AST), markers of liver injury, increased mod-
GSNOR/ mice. In particular, serum levels of both amy-estly at 24 hr after treatment with LPS and declined by
lase and lipase changed little following LPS treatment48 hr (Figures 5A and 5B). By contrast, both ALT and
(Figures 5F and 5G), and no histological abnormalityAST increased markedly in the GSNOR/ mice at 24 hr
was detected.and remained unchanged at 48 hr (Figures 5A and 5B).
Increases in ALT and AST were directly correlated with A protective role for GSNOR was evident in lymphatic
Cell
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Figure 5. Serum Markers of Tissue Injury
Serum was collected 48 hr following control
PBS injection and 24 hr or 48 hr following
LPS injection. Data (mean  SE) are from
4–12 wild-type (open) or GSNOR/ (filled)
mice. Significant pairwise differences are in-
dicated by an asterisk (p  0.015). Markers
assayed were: (A) alanine aminotransferase
(ALT); (B) aspartate aminotransferase (AST);
(C) creatinine; (D) urea nitrogen (BUN); (E) cre-
atine phosphokinase (CPK); (F) amylase; (G)
lipase.
(H) Correlation between ALT (R2  0.85, p 
0.01) or AST (R2  0.94, p  0.01) and liver
SNO in six GSNOR/ mice (48 hr after LPS).
tissue (Figures 6C–6H). At 24 hr after LPS, the two strains Effect of iNOS Inhibition on Tissue Injury
and Survival of GSNOR/ Miceshowed a similar amount and pattern of lymphocyte
apoptosis in thymus, spleen, mesenteric lymph nodes, To establish further the contribution of nitrosative stress
to the pathogenesis of endotoxic shock, we treated LPS-Peyer’s patches, and other lymphoid tissues. However,
whereas the wild-type lymphatic tissues showed little challenged GSNOR/ mice with 1400W, a selective
iNOS inhibitor. Administration of 1400W, initiated 6 hrcell death at 48 hr after LPS (Figures 6C, 6E, and 6G),
the GSNOR/ tissues showed substantial apoptosis following LPS injection, reduced serum nitrate (i.e., NOS
activity) by about 50% (Figure 7A, P  0.015) and liver(Figures 6D, 6F, and 6H). Lymphocyte apoptosis in the
thymus was extensive, especially in cortical regions (Fig- injury by about 90% (Figure 7C, P 0.020), an improve-
ment that coincided with a reduction of liver SNO byure 6D). Further, at 48 hr after LPS, lymphocyte depletion
was more severe in the GSNOR/ thymus than in the about 90% (Figure 7B). Measurements of serum markers
showed that tissue injury was also reduced in kidney,wild-type (Figures 6C and 6D). Thus, GSNOR is required
to protect the immune system from endotoxic injury. pancreas, and muscle (48 hr after LPS treatment; data
Enzymatic Degradation of S-Nitrosothiols
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Figure 6. Histopathology of LPS-Challenged
Mice
Shown are sections of liver (A and B), thymus
(C and D), spleen (E and F), and mesenteric
(pancreatic) lymph node (G and H) of wild-
type (A, C, E, and G) and GSNOR/ (B, D, F,
and H) mice 48 hr after LPS. All the micro-
graphs are of the same magnification, and
the scale bar in (A) is 20m. N, necrotic hepa-
tocyte; T, tingible body macrophage with
phagocytosed apoptotic cells. Each micro-
graph is representative of three animals.
not shown). Most importantly, the survival rate of LPS- whereas PBS (volume control) had little effect (Figure
7D). When administration of 1400W was delayed for 24challenged GSNOR/ mice was significantly improved
by 1400W (Figure 7D versus Figure 3D, P  0.03), hr following LPS injection, allowing SNOs to accumulate
Figure 7. iNOS Inhibition Prevents SNO Elevation, Reduces Liver Injury, and Improves Survival of LPS-Challenged GSNOR/ Mice
(A–C) Serum levels of nitrate (A; n  7), liver S-nitrosothiol (B; n  4) and serum ALT (C; n  5) in GSNOR/ mice that were given 1400W 6
hr following LPS injection (filled columns). Open columns represent the values obtained in the absence of 1400W and are reproduced from
Figures 4A, 4B, and 5A.
(D) Survival of LPS-challenged GSNOR/mice that received either 1400W (n 12; squares) or PBS (n 6; diamonds) 6 hr following LPS injection.
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to hazardous levels, the protection conferred by NOS that is further supported by the observation that the
ratio of SNO to iron nitrosyl compounds at basal condi-inhibition was lost (3 out of 5 female GSNOR/ mice
died). These data strongly suggest that nitrosative stress tions, and of SNO to nitrate or nitrite or both during the
course of endotoxic shock, are increased significantlyimposed by iNOS in GSNOR/ mice is causally impli-
cated in tissue damage and increased mortality. in GSNOR/mice. Inasmuch as measurements of nitrite
and nitrate are the standard means of assessing NO
bioactivity in biological systems, our results raise inter-GSNOR in Septic Shock
esting questions regarding many previous interpreta-The role and function of GSNOR was also investigated
tions.in bacterial septic shock induced by cecal ligation and
GSNO is the only substrate SNO recognized bypuncture (CLP) (Wichterman et al., 1980), an animal
GSNOR, yet deletion of the enzyme results in greatermodel that resembles the human condition. CLP re-
increases in SNO-proteins than in GSNO itself. A similarsulted in significantly higher mortality in GSNOR/ mice
result was obtained in GSNOR-deficient yeast (Liu et(n 9) than in wild-type mice (n 8) (Figure 3E), whereas
al., 2001) and in RBCs exposed to GSNO ex vivo (Jia eta sham control without puncture did not result in death
al., 1996 and T.J.M. and J.S.S., unpublished data). Theseof either GSNOR/ (n  3) or wild-type (n  3) mice
results indicate that at least some key protein SNOs are(data not shown). Following CLP, the levels of liver SNOs
in equilibrium with GSNO both under basal and stress(Figure 4E) and marker enzymes (data not shown) were
conditions (Equation 1), and that the equilibrium appar-significantly higher in GSNOR/ than in wild-type mice.
ently favors protein SNOs. Prompt disposal of GSNO byThus, GSNOR protects mice against SNO-related mor-
GSNOR (Equation 2) acts to drive the equilibrium towardbidity and mortality induced by CLP.
the denitrosylated state. Thus evidently, glutathione
(GSH) cannot effectively or fully terminate SNO signalingDiscussion
or protect proteins from hazardous levels of S-nitrosyla-
tion in the absence of GSNOR.In this study, we demonstrate that: (1) S-nitrosothiols
play an essential role in NO biology, influencing blood
pressure and related homeostatic functions, and con- Protein-SNO  GSH >< GSNO  protein (1)
tributing to the pathogenesis of endotoxic/septic shock;
(2) NO bioactivity is regulated not only at the level of
GSNO  NADH  H >
GSNOR
GSH
GSSG  NH4 (2)synthesis (i.e., NOS) but also by degradation, in particu-
lar by GSNOR; (3) turnover of GSNO influences the level
of whole-cell S-nitrosylation; (4) accumulation of SNOs
can produce a stress on the mammalian organism that GSNOR Protects from Nitrosative Stress in
influences survival, and in particular, nitrosative stress Response to Endotoxin and Bacteria
that is identified with GSNO is implicated in disease We found that mice with elevated iNOS activity are sub-
pathogenesis; (5) GSNOR protects mice from excessive jected to nitrosative stress, characterized by elevated
declines in blood pressure under anesthesia, and from levels of S-nitrosylated proteins. However, it is not un-
tissue injury following endotoxemia; (6) the systems af- less protection afforded by GSNOR is abolished
fected most by GSNOR deficiency include the liver, im- (GSNOR/) that the LPS-challenged mice suffer detri-
mune system, and cardiovascular system. Thus, the cur- mental consequences, including hazardous accumula-
rent paradigm of NO biology, which centers on the tions of S-nitrosylated proteins, and tissue damage. The
activity of NOS, is changed fundamentally by these re- finding that GSNOR protects lymphatic tissues and liver
sults. Our data also provide genetic support for the con- from apoptosis, supports much accumulating evidence
ceptualization of NO biology that involves redox-based that death signaling is regulated by SNOs (Eu et al., 2000;
regulation of proteins through modification at cysteine Haendeler et al., 2002; Mannick et al., 1999; Marshall and
thiols. Stamler, 2002; Matsumoto et al., 2003). That said, all
measures of injury across tissues as well as survival of
the animals, were greatly improved by inhibition of iNOS.GSNOR Is Essential for SNO Metabolism
GSNO reductase is evidently not essential for develop- Collectively our data establish that nitrosative stress is
a major cause of morbidity in GSNOR/ mice.ment, growth, and reproduction of mice. Although it has
been suggested that normal growth and reproduction of GSNOR is but one of many factors that mediate resis-
tance to microbial challenge (Cohen, 2002); its role willADH III-deficient mice requires dietary supplementation
with large amounts of vitamin A (retinol) (Molotkov et be influenced not only by microbial susceptibility to
SNOs, but also by GSNOR’s role in protecting immuneal., 2002), we observed no such requirement in either of
our GSNOR/ mouse strains. The origin of the unusual function (Figure 6). This complexity notwithstanding, re-
cent genetic and chemical evidence suggests that SNOsnutritional requirement reported by Molotkov et al.
(2002) may lie in the deletion construct that was used are produced in mice to counter cryptococcal (de Jesus-
Berrios et al., 2003), salmonella (De Groote et al., 1996),or in the genetic background of the mice.
One principle discovery is that GSNOR is crucial for and tuberculous (MacMicking et al., 1997) infections.
Our findings here indicate that SNOs are also producedSNO metabolism in animals. GSNOR/ mice accumu-
lated higher amounts of S-nitrosothiols than wild-type by the host in additional forms of polymicrobial/gram-
negative sepsis. Specifically, the protection afforded bymice despite comparable levels of NOS expression and
activity. Levels of SNOs in vivo are thus determined not GSNOR was not only observed in the endotoxic model
of shock, but also against CLP-induced bacteremia.only by NOS activities, but also by GSNOR, a conclusion
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GSNOR deficiency also resulted in elevated hepatic lev- effects of anesthesia in endotoxic animals. Moreover,
although our results do not exclude effects of GSNOels of SNOs in the CLP model. In support of relevance
of these mouse models to the human condition, we find exerted centrally or in the kidney (Ortiz and Garvin, 2003;
Stamler, 1999; Stoll et al., 2001), they support the recentthat SNO-Hb levels, which are known to be increased
in the blood of endotoxic animals (Jourd’heuil et al., discovery that RBCs dilate blood vessels (Gonzalez-
Alonso et al., 2002; Jia et al., 1996; McMahon et al.,2000), were several-fold higher in the blood of patients
with gram-negative sepsis (0.0037  0.0010 SNO/Hb, 2002) and the proposition that SNOs in RBCs may con-
tribute to a hypotensive phenotype.n  7) than in healthy controls (0.0010  0.0004 SNO/
Hb, n  12; P  0.01). Taken together, these data sug- The mechanism(s) by which SNOs are both generated
in RBCs and the activity liberated to dilate blood vesselsgest that S-nitrosothiols may play important roles in
both the amelioration and pathogenesis of endotoxic/ (McMahon et al., 2002; Pawloski et al., 2001) is incom-
pletely understood. It has been shown that Hb can reactseptic shock.
with NO (Gow et al., 1999), nitrite (Luchsinger et al.,
2003) or GSNO (Jia et al., 1996; Romeo et al., 2003) toGender
produce SNO-Hb, and that vasodilation by RBCs re-GSNOR deficiency resulted in a 10-fold increase in mor-
quires transfer of the NO from SNO-Hb to RBC mem-tality (versus wild-type) in LPS-challenged female mice,
brane thiols (Pawloski et al., 2001). Additional studiesbut only 2-fold in males. The protective effect of
point to a role for plasma GSNO in dispensing of RBCGSNOR may therefore contribute to the relative resis-
membrane bioactivity (Lipton et al., 2001). Our resultstance of females to septic shock—a phenomenon seen
now establish the importance of GSNO/GSNOR in main-in both animals (Laubach et al., 1998; Zellweger et al.,
taining the levels of RBC-SNO in vivo. Moreover, the1997) and humans (Oberholzer et al., 2000; Schroder et
finding that increases in SNO occur without detectableal., 1998). In this regard, Laubach et al. showed that
increases in other bioactive NO compounds (iron ni-iNOS protects female mice more than male mice from
trosylHb and nitrite) provides strong genetic support forendotoxemia-induced death (Laubach et al., 1998).
the idea that SNOs can mediate NO bioactivity in bloodTaken together, these data suggest that the beneficial
(Jia et al., 1996; Stamler et al., 1992) and tissues (Goweffect of iNOS is nullified by nitrosative stress in
et al., 2002; Stamler et al., 2001).GSNOR/ animals. We speculate that GSNOR is a ge-
netic determinant of sepsis outcome, particularly in fe-
Conclusionmale patients, and that the potential benefits of iNOS
Our results underscore the central role of S-nitrosothiolsinhibition in septic patients will relate to GSNOR activity.
in NO biology and disease. Specifically, the genetic evi-
dence provided in this study suggests that GSNO turn-Hemodynamic Consequence
over is required not only to prevent accumulation ofof GSNOR Deficiency
SNO that predisposes to disease diathesis, but alsoHypotension is one of the most frequent side effects of
for regulating the turnover of SNOs in the context ofanesthesia, but the basis for patient susceptibility is
physiological signaling (e.g., the dispensing of a mes-unknown. Once anesthetized, GSNOR-deficient mice
senger to regulate blood pressure). This homeostaticwere hypotensive (in the absence of LPS challenge). In
role of GSNO reductase is reminiscent of that played byGSNOR-deficient animals, basal SNO levels were in-
superoxide dismutase (SOD): GSNOR affords protectioncreased approximately 2-fold in RBCs, amounts that
against nitrosative stress and influences vascular toneproduce vasodilation in bioassays (McMahon et al.,
in a way that is evocative of SOD protection against2002; Pawloski et al., 2001) and lower blood pressure
oxidative stress and regulation of blood pressure (Didion(or vascular resistance) when either RBCs or SNO-Hb
et al., 2002; Nakazono et al., 1991). Thus, we anticipate(the major RBC SNO) are infused intravenously (Jia et al.,
additional roles for GSNOR in regulation of critical organ1996). It has been shown that urethane or pentobarbital
functions. Finally, inasmuch as studies in endotoxemiaanesthesia markedly potentiates the vasorelaxant and
and bacteremia are paradigmatic of other innate im-hypotensive effects of SNOs administered intravenously
mune, inflammatory, degenerative, and proliferativein rats (Travis et al., 1997). Our results thus point to the
conditions in which iNOS is implicated, it is possiblepossibility that blood pressure under anesthesia may
that nitrosative stress may contribute broadly to diseasereflect SNO bioactivity and may have a genetic basis in
pathogenesis. Diseases characterized by malfunction inGSNOR activity. Interestingly, the hypotensive effects of
S-nitrosylation may represent new therapeutic opportu-iNOS have also been linked to anesthesia. Hypotension
nities and targets for intervention.was greater in pentobarbital-anesthetized wild-type
mice challenged with LPS than in iNOS/ mice (Mac-
Experimental ProceduresMicking et al., 1995), and concentrations of LPS that
lowered blood pressure to comparable degrees in anes- Construction of a GSNOR Targeting Vector
thetized versus conscious iNOS/ mice, produced far A bacterial artificial chromosome (BAC) library derived from genomic
DNA of mouse strain 129sv/CJ7 (Invitrogen) was screened for thegreater hypotension in anesthetized than conscious
GSNOR gene by PCR with primers from exon 8 (MoADH1001se,wild-type mice (MacMicking et al., 1995; Rees et al.,
5-GATGGAAGAGTGTGGAGAGTG) and exon 9 (MoADH1290as, 5-1998). LPS is known to increase levels of SNO-Hb in
CAGTCTCGATTATGCACATTCC) (Foglio and Duester, 1996). Tworodents (Jourd’heuil et al., 2000), and we now report
BAC clones were identified (36c24 and 91m09), and subjected to
similar increases in the blood of patients with sepsis. restriction mapping and Southern blot analysis with probes ex8-9
Collectively, these data suggest that the increased and ex2-3, which were generated from a mouse ADH III cDNA clone
(ATCC, GenBank accession number AA008355) by PCR with primerSNOs derived from iNOS contribute to the hypotensive
Cell
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pairs for exons 8-9 (MoADH1001se, MoADH1290as) and exons 2-3 Nitrite concentrations are higher when measured by CE than by
chemiluminescence (Zunic et al., 1999 and data not shown), but no(MoADH52se, 5-GTGATCAGGTGTAAGGCTGC; MoADH295as, 5-
CTGCCTTCAGCTTCGTGAC), respectively. A SacI fragment con- relative differences versus chemiluminescence were observed.
taining exons 2-4 and a HindIII-BamHI fragment containing exons
7-9 were isolated from BAC clone 91m09 and inserted 5 and 3 to Histology
the neomycin resistance gene (neo) in the vector pPNT (Tybulewicz Organs were fixed with phosphate-buffered formalin and embedded
et al., 1991), respectively (see Figure 1A). The resulting GSNOR in paraffin. Tissue sections, 5–6 m thick, were stained with hema-
targeting vector was confirmed by DNA sequencing and linearized toxylin and eosin (H&E), and examined by light microscopy by a
by NotI. board certified veterinary pathologist (M. Hanes). Apoptosis was
assessed by TUNEL assay.
Generation of GSNOR/ Mice
ES cells derived from 129sv mice were transfected with the linear-
LPS Treatmentized targeting vector and selected for the presence of neo and
LPS (E. coli, serotype 026:B6, Sigma) at a dosage of 150,000 endo-absence of the herpes simplex virus thymidine kinase (tk; Duke
toxin units/g (EU/g) was injected intraperitoneally into C57BL/6 andtransgenic mouse facility). Selected ES clones were first screened
GSNOR/ mice that were matched for age (11–12 weeks old), gen-for homologous recombination by PCR with a neo-derived primer
der, and weight. LPS used for the males was lot number 050K4117(Neo3se, 5-TCTTGACGAGTTCTTCTGAGG) and a GSNOR primer
(15 million EU/mg) and LPS used for the females was lot number(GSNOR3as, 5-CAGTTGACTGTCAATGAACTGG) external to the
101K4080 (3 million EU/mg). Studies done in 45 additional male micehomologous region in the targeting vector (see Figure 1A). This PCR
(22 wild-type and 23 GSNOR/) administered lot number 101K4080,detects a 2.7 kb DNA fragment only in the cells with the targeted
insured that gender and strain differences did not result from adisruption. Recombinant clones were further screened by Southern
batch effect. Phosphate-buffered saline (PBS, 20l/g) was injectedanalyses of SacI- and XbaI-digested genomic DNA with probes
in controls. In additional sets of experiments, LPS-challengedex2-3 and ex8-9, respectively. The correctly disrupted allele shows
GSNOR/ mice were injected subcutaneously with the iNOS inhibi-a 7.3 kb SacI and a 1.8 kb XbaI fragment, whereas wild-type shows
tor 1400W (1 g/g, Cayman) or PBS (10 l/g) at 6, 24, and 30 hra 5.5 kb SacI and a 2.4 kb XbaI fragment (see Figure 1A).
after LPS, or at 24, 42, and 48 hr after LPS.Two correctly targeted ES clones with normal karyotype were
used independently to generate chimeric mice, which were subse-
quently bred with C57BL/6 mice to produce F1 heterozygotes. These Bacterial Sepsis
F1 mice were either mated with each other to produce F2 GSNOR/ Female mice aged 3 months were anesthetized with ketamine (150
mice or further backcrossed with C57BL/6 mice. Two independent mg/kg) and xylazine (10 mg/kg). The cecum was ligated below the
GSNOR/ mouse lines from the two ES clones were established ileocecal valve, and punctured once on the antimensenteric border
after both seven and ten consecutive backcrosses with C57BL/6 with a 26-gauge needle. After surgery, the mice were subcutane-
mice. All mice were fed with standard mouse chow and housed in ously injected with 0.5 ml of normal saline.
a pathogen-free facility.
Septic Shock in Humans
GSNOR Activity
Twelve consecutive adult patients with septic shock in the Duke
GSNO reductase activity was measured by GSNO-dependent NADH
University Medical Center (DUMC) ICU were enrolled. Septic shock
consumption as described previously (Liu et al., 2001).
was defined according to the American College of Cardiology/Soci-
ety of Critical Care Medicine guidelines (1992). The presence of
Blood Pressure gram-negative bacteremia within 72 hr of enrollment was ascer-
Mice aged 6–8 months were anesthetized by a combination of keta- tained from the medical records. The control group consisted of 12
mine (70 mg/kg), xylazine (9 mg/kg), and urethane (1 mg/g). Mean healthy volunteers. Radial arterial and central venous blood samples
arterial pressure was measured through a catheter inserted in the were collected for analysis of RBC NO content (McMahon et al.,
right carotid artery. Blood pressure was also measured in conscious 2002). Informed consent was obtained, and the study was approved
mice by a computerized tail-cuff system (Krege et al., 1995). Values by the DUMC IRB.
shown are the means of daily readings on four consecutive days.
Liver SNOBlood Chemistry, Cell Counts, Nitrite, Nitrate,
Liver homogenates were prepared in lysis buffer (20 mM Tris-HCl,and S-Nitrosothiols
[pH 8.0], 0.5 mM EDTA, 100M diethylenetriamine pentaacetic acid,Blood was obtained by cardiac puncture after animals were euthan-
0.1% NP-40, and 1 mM phenylmethylsulfonyl fluoride). SNO levelsized by CO2 inhalation. The following serum chemistries were quanti-
in the total lysate and in a fraction filtered through a 5 kDa cut-offfied by Antech Diagnostics (Farmingdale, New York): alanine amino-
ultrafiltration membrane (low-mass SNO) were measured by photol-transferase (ALT), aspartate aminotransferase (AST), creatine
ysis-chemiluminescence (Liu et al., 2000b) and normalized for pro-phosphokinase (CPK), urea nitrogen (BUN), creatinine, amylase, li-
tein content.pase, lactate dehydrogenase, alkaline phosphatase, total protein,
globulin, albumin, calcium, magnesium, sodium, potassium, chlo-
ride, phosphorus, glucose, bilirubin, cholesterol, triglycerides, and Statistical Analysis
osmolality. Survival data on day 6 after LPS treatment were analyzed by both
The following parameters were measured with a Pentra 60 C the 	2 test and the Fisher exact test of contingency tables, with
system of ABX Diagnostics (Montpellier, France): hemoglobin, he- similar results. Blood pressure, SNO levels and serum chemistries
matocrit, mean corpuscular volume, and counts of erythrocytes, were analyzed with the Student’s t test or with the nonparametric
leukocytes, neutrophils, lymphocytes, monocytes, eosinophils Mann-Whitney test.
and platelets.
Levels of iron-nitrosyl hemoglobin and SNO-hemoglobin/SNO-
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